Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia

Mackinnon SR., Krojer T., Foster WR., Diaz-Saez L., Tang M., Huber KVM., von Delft F., Lai K., Brennan PE., Arruda Bezerra G., Yue WW.

DOI

10.1021/acschembio.0c00498

Type

Journal article

Journal

ACS Chemical Biology

Publisher

American Chemical Society (ACS)

Publication Date

16/03/2021

Permalink Original publication